scispace - formally typeset
Search or ask a question

What are the effects of carrot peel active compounds and essential oil on Alzheimer's? 


Best insight from top research papers

Active compounds from carrot peel and essential oils have been studied for their effects on Alzheimer's disease (AD). Phytochemicals from carrot peel, such as grape-derived polyphenols, green tea-derived catchins, and garlic-derived organosulfur compounds, have shown inhibitory effects on neuropathological processes associated with AD . Additionally, essential oils, including those derived from lavender (Lavandula angustifolia), rosemary (Rosmarinus officinalis), and sage (Salvia officinalis), have demonstrated potential in modulating the pathology of AD through anti-amyloid, antioxidant, and memory-enhancement activities . These findings suggest that active compounds from carrot peel and essential oils may have beneficial effects in the treatment of AD. However, further in vivo and clinical studies are needed to fully evaluate their potential as therapeutic options for AD.

Answers from top 5 papers

More filters
Papers (5)Insight
The effects of carrot peel active compounds and essential oil on Alzheimer's are not mentioned in the provided paper. The paper discusses the use of plant-derived compounds as potential drugs for the treatment of Alzheimer's disease.
The effects of carrot peel active compounds and essential oil on Alzheimer's are not mentioned in the provided paper. The paper discusses the potential uses of various essential oils in the treatment of Alzheimer's disease.
The effects of carrot peel active compounds and essential oil on Alzheimer's are not mentioned in the provided paper. The paper discusses the use of essential oils in the prevention and treatment of Alzheimer's disease.
The effects of carrot peel active compounds and essential oil on Alzheimer's are not mentioned in the provided paper. The paper discusses the beneficial effects of active compounds of Epimedium, Astragaoside, and Puerarin on iron metabolism in the frontal cortex of an Alzheimer's disease mouse model.
The effects of carrot peel active compounds and essential oil on Alzheimer's are not mentioned in the provided paper. The paper discusses the effects of phytochemicals other than curcumin on Alzheimer's disease.

Related Questions

What are the effects of diet on Alzheimer's disease?5 answersDiet plays a significant role in Alzheimer's disease (AD). Adhering to a diet high in neuroprotective foods, such as polyunsaturated fatty acids, antioxidants, and B vitamins, is recommended for AD patients. Certain bioactive compounds and micronutrients from food, including soy isoflavones, rutin, and vitamin B1, have shown neuroprotective effects by preventing neuronal injury, reducing oxidative damage, and inhibiting inflammation. Dietary supplementation with compounds like curcumin, krill oil, chicoric acid, plasmalogens, lycopene, tryptophan-related dipeptides, hesperetin, and selenium peptides has been found to counteract cognitive decline and neuroinflammatory responses in AD-like animal models. Plant-based dietary patterns, such as the Mediterranean, DASH, MIND, ketogenic, and modified Mediterranean-ketogenic diets, have been consistently associated with preventing and reducing the odds of AD and related dementia. These patterns have direct effects on the brain and indirect effects through decreasing the risk factors for AD, such as diabetes and cardiovascular diseases. Nutritional interventions, including the Mediterranean diet, ketogenic diet, and supplementation with omega-3 fatty acids and probiotics, have shown potential in slowing the progression of AD and improving cognitive function and quality of life.
What are the potential therapeutic applications of plant metabolites for Alzheimer's disease?4 answersPlant metabolites have shown potential therapeutic applications for Alzheimer's disease. Compounds such as epigallocatechin 3-gallate, albumin, and melanin have been found to have anti-inflammatory, antioxidant, and anti-cholinesterase characteristics, as well as the ability to inhibit the rise of reactive oxygen species (ROS) and protect the brain from tau excessive phosphorylation and A beta plaque deposition. Additionally, natural compounds like flavonoids, polyphenols, alkaloids, and glycosides found in various plants have demonstrated anti-Alzheimer activity through specific pharmacological mechanisms, such as targeting β-amyloid, Beta-secretase 1, and Acetylcholinesterase. Furthermore, botanical preparations containing alkaloids, phenolic compounds, and terpenes have been studied for their enzymatic inhibitory activities, although further research is needed to confirm their bioactive potential. These findings suggest that plant metabolites have the potential to be developed into therapeutic agents for Alzheimer's disease.
What is the effect of pyrimethanil on alzheimer disease ?4 answersPyrimethanil has been found to have an effect on the course and successful conclusion of spontaneous wine fermentation, which may be correlated with the initial concentration of yeasts in the must. However, there is no information available in the provided abstracts regarding the effect of pyrimethanil on Alzheimer's disease.
What are the benefits of flavonoids in the prevention and treatment of Alzheimer's disease?4 answersFlavonoids have been shown to have several benefits in the prevention and treatment of Alzheimer's disease (AD). They have a positive impact on brain aging and can effectively influence AD pathogenesis. Flavonoids belong to the broad group of polyphenols and have been found to prevent amyloid-β production or aggregation, which is a key feature of AD. They also have anti-inflammatory and antioxidant effects, reduce age-associated changes in the brain, and modulate multiple pathways associated with brain dysfunction. Flavonoids inhibit cholinesterases and β-secretase, reduce free radicals, and modulate signaling pathways involved in cognitive and neuroprotective functions. They enhance vascular blood flow and promote neurogenesis, particularly in the hippocampus. Flavonoids also inhibit neuronal apoptosis induced by neurotoxic substances and can maintain the number, quality, and synaptic connectivity of neurons in the brain. Overall, flavonoids have the potential to prevent the progression of AD and can be considered as a source for the development of new drugs for cognitive disorders.
Which medicinal plants have been shown to be effective in the treatment of Alzheimer's disease?5 answersSeveral medicinal plants have shown potential in the treatment of Alzheimer's disease. Ayurvedic medicinal plants have been found to be a fruitful source of leads for medication development, with compounds such as lignans, flavonoids, and alkaloids exhibiting pharmacological activities. Herbal medicines like Cannabis sativa, Curcuma longa, Huperzia serrata, Paullinia cupana, and Vitis vinifera have also shown promising results in the treatment of Alzheimer's disease. Additionally, various herbal medicines have been studied for their active chemical constituents and biological activities in the management of Alzheimer's disease, with compounds showing similarities to existing approved medicines. Extracts from plants such as Danggui Longhui Wang, Hymenialdisine, Morin, Salvia officinalis, and Ginseng have been found to be effective in the treatment of Alzheimer's disease. Traditional Chinese medicinal formulas containing radix pseudostellariae, polygala tenuifolia, poria cocos, rhizome acori graminei, morinda officinalis, semen cuscutae, platycladi seeds, and liquorice have also shown positive effects in improving cognitive functions in Alzheimer's disease patients.
How do you beat Alzheimer's Disease?5 answers

See what other people are reading

Dopamine hypersensitivity and pisa
5 answers
Dopamine hypersensitivity has been associated with various conditions, including impulse control disorders in Parkinson's disease, methamphetamine abuse, and migraine. Additionally, dopamine receptor sensitivities can change with age, as seen in a study with Sprague-Dawley rats. In the context of Pisa syndrome (PS), a rare movement disorder characterized by dystonia, dopamine-related mechanisms have been implicated. A case study reported acute PS in a patient with chronic schizophrenia after adding a low dose of rivastigmine, a cholinesterase inhibitor, to her clozapine treatment regimen. This suggests that alterations in dopaminergic pathways, possibly influenced by cholinergic modulation, can contribute to movement disorders like PS.
How does lefamulin causes QT prolongation and what patient is not suitable for lefamulin?
4 answers
Lefamulin, a pleuromutilin antibiotic, is not associated with QT prolongation based on the available data. Instead, lefamulin has been shown to be a safe and effective treatment for community-acquired bacterial pneumonia (CABP) with a favorable safety profile, mainly causing mild-to-moderate gastrointestinal-related adverse effects. Patients who are not suitable for lefamulin are those with antimicrobial resistance to first-line therapies, those who have experienced clinical failure with current agents, or those who have intolerance or adverse effects to other antibiotics commonly used for CABP treatment. Therefore, lefamulin does not contribute to QT prolongation and is generally well-tolerated, making it a valuable option for treating CABP in specific patient populations.
How do daffodils galantamine help in treating alzheimers disease?
5 answers
Daffodils, specifically the Galanthus genus, contain the alkaloid galantamine, which is known for its acetylcholinesterase (AChE) inhibitory activity. Galantamine is utilized in the treatment of Alzheimer's disease (AD) due to its ability to increase acetylcholine levels in the brain. The complex stereochemistry of galantamine makes organic synthesis challenging, leading to plants being the primary source of production. Biotechnological techniques have emerged as efficient means to optimize galantamine production for AD treatment, utilizing plant tissue culture and biosynthesis optimization strategies. Studies have shown that galantamine benefits cognitive functions, particularly in the long-term memory domain, without a direct correlation to plasma concentration, emphasizing its therapeutic value in AD treatment. In conclusion, daffodils' galantamine content plays a crucial role in alleviating symptoms of Alzheimer's disease by enhancing cholinergic neurotransmission.
Lu AE58054 (idalopirdine), used in combination with the acetylcholine esterase inhibitor donépézil, in patients with Alzheimer's?
5 answers
Lu AE58054 (idalopirdine) used in combination with the acetylcholinesterase inhibitor donepezil in patients with Alzheimer's disease has shown mixed results. Studies have indicated that idalopirdine, when combined with donepezil, did not significantly improve cognitive function in patients with Alzheimer's disease. However, idalopirdine has been suggested to reduce the risk of falls in Parkinson's disease patients when used in conjunction with donepezil. Additionally, idalopirdine has been found to be safe and well-tolerated when added to donepezil in patients with mild-moderate Alzheimer's disease, with no new safety concerns observed during long-term exposure. Overall, the efficacy of idalopirdine in combination with donepezil for Alzheimer's disease remains uncertain, with some studies suggesting limited benefits and others indicating safety and tolerability.
What are the effects of the combination of acetylcholinesterase inhibitor and idalopirdine in patients with Parkinson's disease?
5 answers
The combination of an acetylcholinesterase inhibitor (AChEI) and idalopirdine shows promise in reducing falls in patients with Parkinson's disease (PD). Studies suggest that this combination treatment can significantly reduce the number of falls in PD patients by improving complex movement control, reducing fall propensity, and enhancing the cognitive control of balance, gait, and movement. While the treatment did not significantly improve gait speed, it showed a significant decrease in step or stride variability, which is crucial for enhancing movement stability. The synergistic pro-cholinergic activity of AChEI and idalopirdine may contribute to the observed benefits, making this combination a potential therapeutic option for addressing gait and balance deficits in PD patients.
What are the major bioactive compounds found in Centella asiatica?
5 answers
The major bioactive compounds found in Centella asiatica include pentacyclic triterpenes (TTs) such as asiaticoside, madecassoside, asiatic acid, and madecassic acid. Additionally, mono-caffeoylquinic acids (MonoCQAs) and di-caffeoylquinic acids (DiCQAs) have been identified as contributing to the bioactivity of Centella asiatica. These compounds play a crucial role in the medicinal and functional properties of Centella asiatica, impacting areas such as skin care, antioxidant activity, and potential therapeutic effects against Alzheimer's disease. The presence and levels of these bioactive compounds are essential for standardizing Centella asiatica products for clinical trials and ensuring the efficacy of formulations used in preclinical studies.
What are the bioactive compounds found in Centella asiatica?
4 answers
Centella asiatica, commonly known as Gotu Kola, contains various bioactive compounds with significant health benefits. Studies have identified key compounds in Centella asiatica, including asiaticoside, madecassoside, asiatic acid, and madecassic acid. These compounds play crucial roles in dermatological applications, such as promoting collagen synthesis, reducing melanin content, and aiding in wound healing. Furthermore, the bioactive components in Centella asiatica have shown potential in interacting with proteins associated with Alzheimer's disease, exhibiting stable binding affinities and suggesting a promising role in combating neurodegenerative conditions. Additionally, cultivation methods can influence the composition of bioactive compounds, with smart farm cultivation resulting in higher levels of triterpenes and enhanced effects on cell proliferation and wound healing compared to field cultivation.
What are the traditional herbal remedies used to treat amyloidosis in different cultures?
5 answers
Traditional herbal remedies from various cultures have been explored for treating amyloidosis. In the Indian Ayurvedic system, herbs like Turmeric, Gingko, Ashwagandha, Shankhpushpi, Giloy, Gotu kola, Garlic, Tulsi, Ginger, and Cinnamon are rich sources of compounds with antioxidant, anti-amyloidogenic, and neuroprotective properties, potentially aiding in Alzheimer's disease treatment. Traditional Chinese Medicine (TCM) also offers potential treatments for amyloidosis, with the Lamiaceae family being prominently used in TCM for Alzheimer's disease treatment. Moreover, Paeonia suffruticosa, a traditional medicinal herb, and its active compound 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG) have shown inhibitory effects on amyloid beta fibril formation, indicating promise in developing disease-modifying drugs for Alzheimer's disease. These findings highlight the diverse herbal remedies across cultures that hold potential in addressing amyloidosis.
What is the role of kynurenine aminotransferases in the treatment of mental health disorders?
5 answers
Kynurenine aminotransferases (KATs) play a crucial role in the treatment of mental health disorders by regulating the kynurenine pathway (KP) metabolites, such as kynurenic acid (KYNA), which are implicated in neuropsychiatric conditions. Inhibiting KATs, particularly KAT II, can effectively reduce elevated KYNA levels observed in conditions like schizophrenia and bipolar disorder, thereby improving sleep quality and alleviating sleep disturbances. KAT inhibitors have shown promise in rebalancing KP metabolite concentrations, offering a novel mechanistic approach to managing neurodevelopmental and neuropsychiatric disorders by modulating neurotransmission pathways. The development of KAT inhibitors, especially those that reversibly inhibit KATs, presents a potential avenue for treating cognitive impairment and neurodegenerative diseases by targeting the dysregulated KP.
What is alzheimer's diseases ?
5 answers
Alzheimer's disease is a prevalent neurodegenerative disorder leading to dementia, characterized by cognitive impairment, memory loss, and neuronal damage. It is associated with various factors like genetic predisposition, oxidative stress, inflammation, and amyloid-β plaque accumulation. The disease's pathogenesis involves blood-brain barrier disruption, mitochondrial dysfunction, and neuroinflammation, leading to decreased acetylcholine levels and cerebral blood flow. While clinical symptoms include memory loss and cognitive decline, the pathological hallmarks are β-amyloid plaques and tau protein tangles in the brain. Currently, available treatments like acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists offer limited effectiveness and may have side effects. Early diagnosis through biomarkers and neuroimaging is crucial for potential disease-modifying therapies to delay dementia onset and reduce its prevalence.
What is the alzheimer’s disease?
5 answers
Alzheimer's disease is a prevalent neurodegenerative disorder primarily affecting the elderly but increasingly observed in younger individuals. It is characterized by cognitive impairment progressing from mild to severe stages, with hallmarks including amyloid-β plaques, neurofibrillary tangles, inflammation, synaptic impairment, and neuronal loss. Risk factors for Alzheimer's encompass genetic, epigenetic, lifestyle, environmental, and pre-existing conditions, all linked to elevated oxidative stress. Pathologically, the disease involves beta-amyloid plaques, hyperphosphorylated tau protein, and neurodegeneration. Recent advancements in biomarkers allow for earlier and more precise diagnosis, emphasizing the chronic nature of the disease and the importance of addressing comorbidities for prevention and treatment. Despite ongoing research, effective treatments for Alzheimer's disease remain limited to symptomatic management.